Acomplia (rimonabant) is the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1). Acomplia is used in the treatment of obesity and related conditions.
Use as directed by doctor. However, doses consist of one tablet taken orally every day before breakfast. It should be swallowed with a full glass of water.
Side effects in the trial on Acomplia in obesity were vomiting and nausea, forcing about 19 percent of patients to leave the trial versus 13 percent of those who took placebo.
Acomplia should only be used with patients who have a BMI over 30 or a BMI over 27 with associated risk factors. Do not take while on anti-depressive medication. Acomplia should be cautiously in patients with moderate renal impairment, epilepsy, patients using potent inhibitors and rare hereditary disorders and glucose intolerance. In addition those over 75 should take care when using the Acomplia. Those who should not take Acomplia include those with severe renal impairment, uncontrolled psychological disorders, a cardiovascular event in the last six months and patients who are breastfeeding or pregnant.
Take any missed dose as soon as possible but not if it is within 8 hours of the next dose. If it is time for the next dose, skip the missed dose and resume your regular schedule. Do not "double-up" the
Store at room temperature and keep away from moisture and sunlight. Do not store in the bathroom.